BRCA2 and breast cancer: To determine if BRCA1/2 may facilitate HR-dependent lesion bypass of APOBEC-induced DNA damage in breast cancer, we assessed SBS13 mutations for replicative asymmetry associated with deamination of the lagging strand template in the absence of BRCA1 or BRCA2 (Fig. 6C).